Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord blood Tregs in type 1 diabetes
NCT02932826Phase 2Unknown
- Sponsor
- The Second Xiangya Hospital
- Start
- Oct 2016
- Primary completion
- Jun 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood regulatory T cells in type 1 diabetes mellitus (T1D), sponsored by The Second Xiangya Hospital. Status: unknown.
02
Drugs
umbilical cord blood regulatory T cells
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02932826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02932826.